FDA DEVICE FACTS
TiGer Shark™ System
Choicespine, LP
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Choice Spine TiGer Shark™ System is indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). These patients should have had six (6) months of non-operative treatment. This device is designed to be used with autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft. This device is designed for use with supplemental fixation that is cleared for use in the lumbar spine. Materials: The implants are made from titanium alloy (Ti-6Al-4V ELI) per ASTM F3001, Class C and will be provided sterile. Instruments will be provided non-sterile, but will be steam sterilized before use. The instrumentation is made from 455 SS: and 17-4 SS per ASTM F899 and ASTM A564. Non-Clinical Testing: Static Compression - Per ASTM F2077 Static Compression Shear - Per ASTM F2077 Dynamic Compression - Per ASTM F2077 Dynamic Compression Shear - Per ASTM F2077 Expulsion – N/A Subsidence – per ASTM F2267
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。